Tue, February 11, 2025
[ Tue, Feb 11th ]: Nature
Your brain is full of microplastics: are they harming you?
[ Tue, Feb 11th ]: MSN
Special Report-China builds space alliances in Africa as Trump cuts foreign aid
[ Tue, Feb 11th ]: Firehouse
Fire Studies: Fireground Strategies: The Science of Suppression vs. Extinguishment
[ Tue, Feb 11th ]: MSN
New study makes alarming connection between tap w .. f rare cancers: 'It's worth researching ... more'
[ Tue, Feb 11th ]: MSN
How gender shapes perceptions of safety in urban parking spaces
[ Tue, Feb 11th ]: Reuters
China builds space alliances in Africa as Trump cuts foreign aid
[ Tue, Feb 11th ]: techUK
AI Action Summit: Day 4
[ Tue, Feb 11th ]: Yahoo
How Edward Snowden's Leaks Benefited China
[ Tue, Feb 11th ]: MercoPress
Uruguay's President-elect Orsi appoints key figur .. for science, technology, and innovation agencies
[ Tue, Feb 11th ]: MSN
A Tech Power Playbook for Donald Trump 2.0
[ Tue, Feb 11th ]: MSN
International Day Of Women And Girls In Science 2 .. rything About History, Theme, Significance & More
[ Tue, Feb 11th ]: MSN
Tiny water-based reactors could help pharmaceutical industry avoid toxic solvents
[ Tue, Feb 11th ]: Forbes
New Hampshire Bill Proposes Fewer Requirements For High School Graduation
[ Tue, Feb 11th ]: MSN
AZoNetwork Honors Women in STEM on the 10th Anniversary of IDWGS
Mon, February 10, 2025
[ Mon, Feb 10th ]: NextBigFuture
What Is the Game With Elon Bidding $97.5 Billion for OpenAI?
[ Mon, Feb 10th ]: WKTV
AI Wants to Fix Your Love Life. Can It Really Be Hacked?
[ Mon, Feb 10th ]: MLive
Without federal funding, Michigan youth STEM program suddenly shuts down
[ Mon, Feb 10th ]: Sky
What is the AI Action Summit in Paris and what outcomes can we expect?
[ Mon, Feb 10th ]: Vanguard
Saleeman Adedoyin Saleeman: A leading tech innovator with a purpose
[ Mon, Feb 10th ]: Invezz
MuskIt Launches Major 100M Token Buyback to Strengthen Utility and Drive Growth
[ Mon, Feb 10th ]: BBC
South Africa mourn di death of dia first female nuclear scientist wey die at 37
[ Mon, Feb 10th ]: BBC
South Africa mourns pioneering female nuclear scientist
[ Mon, Feb 10th ]: MSN
Oncocyte secures $29.1 million to advance FDA assay
[ Mon, Feb 10th ]: MSN
Tributes pour in following death of nuclear scientist, Senamile Masango
[ Mon, Feb 10th ]: MSN
Nuclear engineering firm moves into new Oxfordshire office
[ Mon, Feb 10th ]: MSN
Winner of InterswitchSPAK 6.0 receives ?15 million scholarship, other exciting prizes
[ Mon, Feb 10th ]: TechCrunch
AI pioneer Fei-Fei Li warns policymakers not to let sci-fi sensationalism shape AI rules
[ Mon, Feb 10th ]: MSN
Unused funds, stalled projects: Audit flags wasted potential of IMTech, Chandigarh
[ Mon, Feb 10th ]: MSN
Detroit robotics teams ready up for high stakes challenge
[ Mon, Feb 10th ]: Forbes
Alpha School: Using AI To Unleash Students And Transform Teaching
[ Mon, Feb 10th ]: MSN
Data science and AI: The twin engines powering the renewable energy revolution
[ Mon, Feb 10th ]: Forbes
Exciting Hotel Spa Treatments To Try In London
[ Mon, Feb 10th ]: MSN
Who is Nikhil Rajpal? All about the Indian-origin techie who is part of Elon Musk's DOGE team
Sun, February 9, 2025
[ Sun, Feb 09th ]: Newslaundry
50% more women in higher education in India, but fewer choose engineering, IT
[ Sun, Feb 09th ]: manilatimes
UTM Open and Distance Learning: Empowering Learners Globally
[ Sun, Feb 09th ]: Newsweek
Pete Davidson is 'Alien Ambassador' in Gordon Ramsay's Super Bowl LIX Ad
[ Sun, Feb 09th ]: MSN
The forgotten magic of CCD sensors: Why I won't give them up!
[ Sun, Feb 09th ]: MSN
Ending war is possible through local action, says Natalya Dinat at All India Science Conference
[ Sun, Feb 09th ]: ProPakistani
Science Ministry Defies Rightsizing Plan to Hire New Department Chief With Huge Salary
[ Sun, Feb 09th ]: MSN
Quantum sensing technology opens new doors in drug development
[ Sun, Feb 09th ]: MSN
Why Ultra Clean Holdings (UCTT) Is Skyrocketing So Far In 2025?
[ Sun, Feb 09th ]: NextBigFuture
Could DOGE End Individual Income Taxes and Eliminate the IRS?
[ Sun, Feb 09th ]: businessday
Top 10 African countries with the most military-age youth
[ Sun, Feb 09th ]: MSN
Space tech company looking to build the world's biggest pool in Cornwall
[ Sun, Feb 09th ]: MSN
Presi's Snigdha 1st woman researcher from West Bengal to go on Antarctic Ocean expedition
[ Sun, Feb 09th ]: MSN
How 'Companion's Subversive Approach to AI Succeeds On-Screen
[ Sun, Feb 09th ]: MSN
Civ 7: All Antiquity Age Unique Civic Trees & How To Use Them
[ Sun, Feb 09th ]: owensborotimes
KY VALOR places 100 veterans in jobs with Kentucky employers; Rep. Johnson helped shape initiative

Oncocyte secures $29.1 million to advance FDA assay

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. e-secures-29-1-million-to-advance-fda-assay.html
  Print publication without navigation Published in Science and Technology on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
IRVINE, Calif. - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, has announced a funding round led by existing investors, including strategic partner Bio-Rad Laboratories, Inc. (NYSE: NYSE:BIO),
Oncocyte Corporation has successfully raised $29.1 million through a private placement of common stock and warrants, aimed at advancing its FDA-cleared VitaGraft™ Kidney assay. This financial boost will support the company's efforts to expand its product offerings in the transplant monitoring sector. The VitaGraft Kidney assay, which measures donor-derived cell-free DNA (dd-cfDNA) to assess kidney transplant health, has already received FDA clearance and is designed to help clinicians detect rejection early, potentially improving patient outcomes. The funds will also be used for general corporate purposes, including working capital and further development of Oncocyte's diagnostic pipeline.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biology/oncocyte-secures-29-1-million-to-advance-fda-assay/ar-AA1yKVrB ]